Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

01 January 2008

Evaluation of a commercially available whole blood calibrator and control kit for the analysis of cyclosporin A, everolimus, sirolimus and tacrolimus using LC/MS/MS technology

A. M. Taylor, T. N. Gamble, D. Blake, T. Drury, M. Ehrdhard

Ann Transplant 2008; 13(1): 36-37 :: ID: 880195

Abstract

Background: Liquid chromatography-tandem mass spectrometry (LC/MS/MS) is a powerful technique for the simultaneous determination of cyclosporin A, tacrolimus, sirolimus and everolimus in whole blood. LC/MS/MS has the benefits of lower detection limits, greater specificity and a broader dynamic range than commercial immunoassays. This paper evaluates the use of a commercially available kit from Recipe GmbH of whole blood calibrators and controls with a quick and simple sample preparation method for LC/MS/MS determination of four immunosuppressants.
Material/Methods: Samples were prepared by adding 200 μL of protein precipitation reagent containing internal standards to 100 μL of whole blood (unknown, calibrators and controls). Samples were then vortexed and centrifuged. Two-dimensional chromatography was performed on the supernatant, with detection by LC/MS/MS using multiple reaction monitoring (MRM) in positive mode. Mass spectrometer parameters were optimized for each analyte.
Results: The whole blood calibrator kit contained 7 calibrators including a blank. The LC/MS/MS assay showed excellent linearity over the concentration range with calibration regression coefficient ranging from 0.9994 to 0.9998. The intra-assay accuracy and precision was within the 20% cutoff, with the exception of the lowest concentration calibrator. Inter-assay accuracy ranged from 89-102% for the low concentration quality control, with % CVs ranging from 5.5-17%. Unknown sample results show good correlation with results obtained from a separate laboratory that prepares their own calibrators and controls in-house.
Conclusions: This study has demonstrated the successful use of a commercially available kit for whole blood calibrators and controls for the determination of four immunosuppressants in unknown samples by LC/MS/MS.

Keywords: Chromatography, immunosuppressants, Sirolimus

Add Comment 0 Comments

In Press

Original article  

Preoperative Evidence-Based Practice for Prevention of Early Postoperative Infections in Patients Receiving...

Ann Transplant In Press; DOI: 10.12659/AOT.943610  

Original article  

Prediction of Renal Graft Function 1 Year After Adult Deceased-Donor Kidney Transplantation Using Variables...

Ann Transplant In Press; DOI: 10.12659/AOT.944603  

Original article  

Impact of Donor-Recipient Relationship on Long-Term Outcomes in Living-Related Donor Kidney Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.945065  

Case report  

Successful Interventional Therapy for Portal Vein Stenosis after Ex Vivo Liver Resection and Autotransplant...

Ann Transplant In Press; DOI: 10.12659/AOT.944851  

Most Viewed Current Articles

05 Apr 2022 : Original article   12,824

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   9,807

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

12 Jan 2022 : Original article   9,234

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

15 Mar 2022 : Case report   7,029

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358